Business Description
Aadi Bioscience Inc
NAICS : 325412
SIC : 2834
ISIN : US00032Q1040
Description
Aadi Bioscience Inc is a clinical-stage biopharmaceutical company developing precision therapies for genetically-defined cancers. Aadi's primary goal is to bring transformational therapies to cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes, where other mTOR inhibitors have not or cannot be effectively exploited due to problems of pharmacology, effective drug delivery, safety, or effective targeting to the disease site. It has one operating segment, which is the business of developing and commercializing proprietary therapeutic. Geographically, it is located in the United States.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 85.91 | |||||
| Equity-to-Asset | 0.79 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | -0.02 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -2.36 | |||||
| Beneish M-Score | -1.34 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 10.4 | |||||
| 3-Year EBITDA Growth Rate | -167.4 | |||||
| 3-Year EPS without NRI Growth Rate | -144.5 | |||||
| 3-Year FCF Growth Rate | -57.1 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 55.93 | |||||
| 9-Day RSI | 47.87 | |||||
| 14-Day RSI | 45.96 | |||||
| 6-1 Month Momentum % | -44.95 | |||||
| 12-1 Month Momentum % | -69.51 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.72 | |||||
| Quick Ratio | 4.48 | |||||
| Cash Ratio | 4.12 | |||||
| Days Inventory | 498.01 | |||||
| Days Sales Outstanding | 66.87 | |||||
| Days Payable | 556.92 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -5.6 | |||||
| Shareholder Yield % | 0.03 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 88.47 | |||||
| Operating Margin % | -295.36 | |||||
| Net Margin % | -270.04 | |||||
| FCF Margin % | -261.66 | |||||
| ROE % | -49.88 | |||||
| ROA % | -42.25 | |||||
| ROIC % | -1092.64 | |||||
| ROC (Joel Greenblatt) % | -1569.45 | |||||
| ROCE % | -48.07 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 2.12 | |||||
| PB Ratio | 0.45 | |||||
| Price-to-Tangible-Book | 0.45 | |||||
| EV-to-EBIT | 0.92 | |||||
| EV-to-EBITDA | 0.92 | |||||
| EV-to-Revenue | -2.48 | |||||
| EV-to-Forward-Revenue | 0.49 | |||||
| EV-to-FCF | 0.95 | |||||
| Price-to-Net-Current-Asset-Value | 0.48 | |||||
| Price-to-Net-Cash | 0.58 | |||||
| Earnings Yield (Greenblatt) % | 108.7 | |||||
| FCF Yield % | -134.98 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Aadi Bioscience Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 22.589 | ||
| EPS (TTM) (€) | -2.262 | ||
| Beta | 0 | ||
| Volatility % | 88.7 | ||
| 14-Day RSI | 45.96 | ||
| 14-Day ATR (€) | 0.069095 | ||
| 20-Day SMA (€) | 1.782 | ||
| 12-1 Month Momentum % | -69.51 | ||
| 52-Week Range (€) | 1.43 - 7.8 | ||
| Shares Outstanding (Mil) | 24.55 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Aadi Bioscience Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Aadi Bioscience Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Aadi Bioscience Inc Frequently Asked Questions
What is Aadi Bioscience Inc(FRA:3350)'s stock price today?
The current price of FRA:3350 is €1.71. The 52 week high of FRA:3350 is €7.80 and 52 week low is €1.43.
When is next earnings date of Aadi Bioscience Inc(FRA:3350)?
The next earnings date of Aadi Bioscience Inc(FRA:3350) is 2024-05-10 Est..
Does Aadi Bioscience Inc(FRA:3350) pay dividends? If so, how much?
Aadi Bioscience Inc(FRA:3350) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers